Archive for January 2014

Bioterrorism

The anthrax and related bioterror scares put quite a strain on the information resources of the homeopathic industry.

Read More

Diabetic Homeopathic Products

AAHP fully supports the Food and Drug Administration position that OTC drug product labels shall bear indications for use consistent with conditions amenable to self diagnosis and treatment.

Read More

Overview of Homeopathic Drug Product Regulation

The Homeopathic Pharmacopoeia Convention of the United States (HPCUS) is responsible for the publication of the Homoeopathic Pharmacopoeia of the United States* (HPUS*). Through its ongoing work, the HPCUS offers assurances that homeopathic medications are safe, accessible and legal in the United States.

Read More

Avian Flu

AAHP wishes to inform the public of its view of the sale of homeopathic medication to prevent or treat Avian Flu.

Read More

The AAHP Lobbies Congress on the Drug Quality And Safety Act

The issue of pharmaceutical compounding came to the fore in 2012 when it was reported that more than 50 deaths and widespread serious medical problems were the result of fungal meningitis linked to contaminated products from the New England Compounding Center (NECC).

Read More

Anthrax and Anthracinum

The anthrax and related bioterror scares have put a strain on the information resources of the homeopathic industry.

Read More

Swine Flu H1N1

AAHP wishes to inform the public of its view of the sale of homeopathic medication to prevent and/or treat Swine Flu H1N1.

Read More